Medtronic plc.

Open: 75.14 Close: 74.76 Change: -0.38

Don't invest in Medtronic plc. before reading this automated analysis produce by an AI.

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, improve, MDT, stock, high, healthcare, and the most common words in the summary are: medtronic, stock, plc, mdt, job, market, medical, . One of the sentences in the summary was: Medtronic PLC (MDT) stock has gained 1.26% while the S&P 500 …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC (MDT) stock has gained 1.26% while the S&P 500 has fallen -0.05% as of 3:03 PM on Thursday, Nov 16. The Score for MDT is 34, which is 32% below its historic median score of 50, and infers higher risk.

Today's News

Medtronic PLC (MDT) stock has gained 1.26% while the S&P 500 has fallen -0.05% as of 3:03 PM on Thursday, Nov 16. Medtronics PLC has a Bullish sentiment reading. Medtronic has a market cap of $99.47 billion. The U.S. Food and Drug Administration on Friday approved the use of Medtronics (MDT.N) treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by drugs. U.S. Food and Drug Administration approves use of Medtronic treatment device in surgery called renal denervation in patients whose high blood pressure cannot be controlled. Majority of americans expect ai to improve healthcare by 2024, survey by medtronic and morning consult reveals. 61% of respondents optimistic ai can improve diagnoses and detect health problems, 56% say ai will improve healthcare access. Medtronic Plc (MDT) Sits On Its Hands At $75.14 – Stocks Register. A majority of Americans are optimistic that AI will improve healthcare. Medtronic PLC stock price is 74.76 USD today. The Score for MDT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. Medtronic raised its F2024 organic revenue growth guidance and expects its full-year gross margin to be around 65.5%, a slight increase from its prior estimate. Josh Jennings has given a Buy rating to Medtronics stock. Medtronic PLCs solvency score is58/100. The higher the solveny score, the more solvent the company is. Wall Street analysts forecast MDT stock price to rise over the next 12 months. Medtronic (mdt) to release quarterly earnings on t Tuesday - defense world. Analysts expect $5 EPS for the current fiscal year. Federal Circuit backs Patent Trial and Appeal Boards finding Medtronic failed to show a catheter patent owned by a rival was invalid. Lantheus Holdings, Inc. says medtronic cant revive patent challenge - law360.com. Medtronic will distribute Allurions swallowable weight-loss balloon. FluidAI Medical Teams Up with Medtronics for Remote Monitoring via DIGITALs Continuous Connected Patient Care Project. Medtron announces FDA approval of minimally invasive device. A majority of Americans are optimistic that AI will improve healthcare in 2024, according to a new survey from Medtronic and Morning Consult. Medtronic wins U.S. Chamber of Commerce Foundation 2023 Citizens Award. LABS: SPICE named Digital Public Good. Medtronics named to 100 Best Corporate Citizens of 2023.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, improve, MDT, stock, high, healthcare, and the most common words in the summary are: medtronic, stock, plc, mdt, job, market, medical, . One of the sentences in the summary was: Medtronic PLC (MDT) stock has gained 1.26% while the S&P 500 has fallen -0.05% as of 3:03 PM on Thursday, Nov 16. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #plc #mdt #job #market #medical.